Germany Exosomes Market Size & Outlook, 2023-2030
Germany exosomes market, 2018-2030 (US$M)
Related Markets
Germany exosomes market highlights
- The Germany exosomes market generated a revenue of USD 7.3 million in 2023 and is expected to reach USD 56.3 million by 2030.
- The Germany market is expected to grow at a CAGR of 34% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Exosomes market data book summary
| Market revenue in 2023 | USD 7.3 million |
| Market revenue in 2030 | USD 56.3 million |
| Growth rate | 34% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Instruments, Services |
| Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
Other key industry trends
- In terms of revenue, Germany accounted for 5.1% of the global exosomes market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany exosomes market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 54.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exosomes Market Scope
Exosomes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany exosomes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exosomes market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 45.21% in 2023. Horizon Databook has segmented the Germany exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
German players are involved in collaborations and partnerships with market leaders for the development of new products using existing technology. For instance, in February 2017, Merck KGaA entered into an agreement with Exosome Diagnostics, Inc. to use the latter’s platforms for the capture and quantitative analysis of exosomes from protein as well as nucleic acid.
The company aims to use this technology to develop therapeutics for oncology. Exosome Diagnostics signed another agreement in August 2017 with CareFirst BlueCross BlueShield to evaluate the clinical outcome of its new products along with the analysis of costs related to the available healthcare coverage.
Furthermore, German Federal Ministry for Education and Research allocates grants to support the development of novel diagnostic tests for complicated health conditions such as cancer. Ludwig Maximilian University, Munich is involved in the development of diagnostic cancer tests based on plasma-derived exosomes.
Reasons to subscribe to Germany exosomes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Germany exosomes market databook
-
Our clientele includes a mix of exosomes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany exosomes market , including forecasts for subscribers. This country databook contains high-level insights into Germany exosomes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Germany exosomes market size, by product, 2018-2030 (US$M)
Germany Exosomes Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
